NPK & Molecular You Launch Collaboration in Precision Healthcare and Gut Health

January 30th, 2026

NPK signs MOU with Canadian precision healthcare company ‘Molecular You’, the collaboration displaying momentum in precision healthcare and preventive medicine based on microbial metabolites.

NPK Co., Ltd., a manufacturer of health functional foods and a company specializing in microbial metabolome research (CEO Kim Sang-joon), announced the signing of a Memorandum of Understanding (MOU) with the Canadian precision healthcare company Molecular You. This agreement establishes cooperation in the fields of precision healthcare and preventive medicine, based on microbial metabolomics.

Under this agreement, both companies plan to progressively pursue:

• Joint research on microbial metabolites and biomarkers.
• Development of functional ingredients and health functional foods based on precise health analysis data.
• Advancement of AI-based personalized healthcare solutions.
• Joint entry into the global market.

Molecular You is a Canadian biotech firm known for its precision healthcare platform. This platform analyzes hundreds of biomarkers from a single blood test and uses AI algorithms for early disease risk prediction. Its prevention- and prediction-oriented healthcare model is attracting significant attention in the North American market. NPK has established distinct competitiveness in gut health and metabolic balance through its raw material development technology, which is rooted in microbial metabolome research, and its capabilities in manufacturing health functional foods. Notably, NPK is continuously expanding its research into functional materials derived from microbial metabolites.

Through this MOU, the two companies plan to combine Molecular You’s multi-biomarker and AI analysis technology with NPK’s microbial metabolome research and productization capabilities. The goal is to introduce a scientific and practical customized health solution based on individual biometric data. An NPK official stated, “This collaboration is a significant turning point, linking microbial metabolome research with precision healthcare data.” They added, “We will develop this into a global cooperation model that sets new standards for disease prevention and health management.”

Molecular You CEO, Jim Kean, commented, “NPK is a partner with high research capabilities and extensive commercialization experience in the field of microbial metabolites.” They continued, “This agreement will accelerate the expansion of the global precision healthcare ecosystem, including entry into the Asian market.”.  In the future, based on the results of their joint research, both companies plan to expand the scope of collaboration into various areas, such as precision nutrition, gut-immune linked healthcare, and prevention-focused health management platforms.